Credit: Shutterstock. Researchers studied the changes of pulmonary artery systolic pressure among patients with interstitial lung disease associated with systemic sclerosis receiving rituximab therapy ...

Results did not materially differ when restricting the analyses to participants free of symptoms of shortness of breath. Structural and functional echocardiographic parameters of subclinical cardiac ...

Parker et al. 4 reported immediate changes in the respective pressures in 21 patients during mitral commissurotomy — usually an immediate drop. The percentage reduction was higher for the pressure in ...

Pulmonary artery systolic pressure (PASP) increases during late life and predicts the development of dyspnea, highlighting the importance of risk factor assessment and control over the life course, ...

More than three-quarters of patients undergoing TAVR present with some degree of pulmonary hypertension, but this has no bearing on subsequent mortality, researchers have found. Rather, what matters ...

Right ventricular end-systolic elastance to end-systolic arterial elastance coupling in excess of 0.68 was linked with preserved right ventricular function and better survival outcomes in patients ...

Association between hemoglobin (Hb) improvement and patient-reported outcomes (PROs) in patients (pts) with myelofibrosis (MF) and anemia: Post hoc pooled analysis of momelotinib (MMB) phase 3 trials.

This drug causes pulmonary and systemic vasodilation, which positively affects hemodynamics, decreasing PVR and median pulmonary arterial pressure and increasing cardiac output and the cardiac index.

PAH has been shown to be related to adipocyte dysfunction, obesity, and estrogens. CYP1B1 is highly expressed in adipose tissue and overexpressed in pulmonary artery smooth muscle cells in patients ...